Literature DB >> 12671933

K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671933

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  87 in total

Review 1.  Primer on renal transplantation.

Authors:  Asha Moudgil
Journal:  Indian J Pediatr       Date:  2012-06-05       Impact factor: 1.967

2.  Approach to cardiovascular disease prevention in patients with chronic kidney disease.

Authors:  Cristina Karohl; Paolo Raggi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

3.  Primary care management of chronic kidney disease.

Authors:  Adrienne S Allen; John P Forman; E John Orav; David W Bates; Bradley M Denker; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2010-10-05       Impact factor: 5.128

Review 4.  Clinical assessment and management of dyslipidemia in patients with chronic kidney disease.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-06-22       Impact factor: 2.801

Review 5.  PCSK9 in chronic kidney disease.

Authors:  P Pavlakou; E Liberopoulos; E Dounousi; M Elisaf
Journal:  Int Urol Nephrol       Date:  2017-01-13       Impact factor: 2.370

Review 6.  HMG-CoA reductase inhibitors and the kidney.

Authors:  Vito M Campese; Bassel Hadaya; Josephine Chiu
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 7.  Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines.

Authors:  Satoru Kuriyama
Journal:  Clin Exp Nephrol       Date:  2008-01-09       Impact factor: 2.801

Review 8.  Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.

Authors:  Roberto Scarpioni; Marco Ricardi; Vittorio Albertazzi; Luigi Melfa
Journal:  World J Nephrol       Date:  2012-12-06

9.  Evaluation of a training and communication-network nephrology program for community pharmacists.

Authors:  Lyne Lalonde; Michelle Normandeau; Diane Lamarre; Anne Lord; Djamal Berbiche; Louise Corneille; Louis Prud'homme; Marie-Claude Laliberté
Journal:  Pharm World Sci       Date:  2008-09-19

Review 10.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.